Merck
MRK
#47
Rank
โ‚น31.255 T
Marketcap
โ‚น12,655
Share price
0.45%
Change (1 day)
72.79%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): โ‚น305.21

According to Merck's latest financial reports the company's current EPS (TTM) is โ‚น345.16. In 2025 the company made an earnings per share (EPS) of โ‚น705.83 an increase over its 2024 EPS that were of โ‚น652.61.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น305.21-56.76%
2025โ‚น705.838.15%
2024โ‚น652.614308.46%
2023โ‚น14.80-97.32%
2022โ‚น553.2410.92%
2021โ‚น498.7884.68%
2020โ‚น270.08-27.2%
2019โ‚น370.9863.44%
2018โ‚น226.98151.11%
2017โ‚น90.39-54.58%
2016โ‚น198.9930.21%
2015โ‚น152.82-61.99%
2014โ‚น402.01180.51%
2013โ‚น143.31-31.82%
2012โ‚น210.206.62%
2011โ‚น197.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น843.35 144.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น677.80 96.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น126.48-63.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น348.42 0.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,725 689.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,398 305.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น247.14-28.40%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น343.73-0.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น375.23 8.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น132.28-61.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel